Biotricity Inc. BTCY
0.07
0.00
0.00%
as of 25 Sep
- Market cap
- $10.9M
- P/E
- 0.0×
Follow BTCY
Growth Flags
show if company had growth for consecutive years
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 9.75% | 9.38% | 14.19% | 15.07% |
+8 more TTM periods Free account |
|
| (57.12%) | (51.76%) | (80.47%) | (83.81%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
10.85% | 10.00% | 24.97% | 26.93% | |
Average Days of Receivables |
53.36 | 66.91 | 37.29 | 50.80 | |
Free Cash Flow per Share |
0.01 | (0.03) | (0.04) | (0.02) | |
Free Cash Flow |
0.16 | (0.72) | (1.10) | (0.45) | |
Piotroski F-Score |
5.00 | 5.00 | 4.00 | 6.00 | |
| Other line items | |||||
Cash ROIC |
(1.96%) | 9.15% | 14.78% | 6.02% | |
Accounts Receivable Turnover |
7.70 | 6.97 | 10.98 | 8.38 | |
Accounts Payable Turnover |
0.35 | 0.37 | 0.35 | 0.36 | |
Inventory Turnover |
1.89 | 2.11 | 1.65 | 1.49 | |
Average Days of Payables |
1,117.44 | 1,073.78 | 1,065.81 | 949.19 | |
Days of Inventory on Hand |
171.19 | 160.55 | 246.66 | 270.82 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
16.72% | 17.28% | 16.15% | 16.06% | |
Selling, General and Administrative Expense of Revenue |
55.20% | 53.09% | 64.02% | 66.88% | |
Share Based Compensation of Revenue |
2.22% | 0.18% | 10.09% | 10.59% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
(0.05) | 0.23 | 0.23 | 0.09 | |
Depreciation/Fixed assets |
368.32 | 208.83 | 147.59 | 123.77 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Revenue per Share |
0.71 | 0.59 | 0.56 | 0.56 | |
Operating CF per Share |
0.01 | (0.03) | (0.04) | (0.02) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
(21.00%) | (19.56%) | (30.40%) | (32.27%) |
Columns are period end dates